Skip to main content
Clinical Trials/NCT05104307
NCT05104307
Completed
Not Applicable

Echocardiogram and Cardiac Performance System (CPS) Ejection Fraction Validation Study

Stephen Esper1 site in 1 country79 target enrollmentNovember 9, 2021
ConditionsHeart Diseases

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Diseases
Sponsor
Stephen Esper
Enrollment
79
Locations
1
Primary Endpoint
Cardiac Performance System electronic data for Pulmonary Artery Pressure
Status
Completed
Last Updated
last year

Overview

Brief Summary

Non-significant risk device study to conduct evaluation of the performance of new device for monitoring of cardiac function (based on previous iterations 510(k) 173156)

Detailed Description

This validation study will help to establish feasibility of using the CPS monitor to screen patients for ejection fraction (EF), CO, PASP and wedge pressure compared to a standard echocardiogram. No clinical decisions will be made as a result of the CPS device EF value and this measurement will be taken for comparison purposes only.

Registry
clinicaltrials.gov
Start Date
November 9, 2021
End Date
January 2, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Stephen Esper
Responsible Party
Sponsor Investigator
Principal Investigator

Stephen Esper

Assistant Professor

University of Pittsburgh

Eligibility Criteria

Inclusion Criteria

  • Patients over 18 scheduled for a standard echocardiogram

Exclusion Criteria

  • Patients with heart transplant history
  • Patients with a Implanted Left Ventricular Assist Device (LVAD)
  • Patients who have surgical scars, wounds, or bandages at the site of sensor placement
  • Inadequate TTE imaging windows in left lateral position
  • Otherwise deemed by the investigator as medically unfit to participate
  • Chest deformities including, for example, pectus excavatum

Outcomes

Primary Outcomes

Cardiac Performance System electronic data for Pulmonary Artery Pressure

Time Frame: 60 minutes during Echocardiography procedure

Cardiac function metric measurement including Pulmonary Artery Pressure to report in mmHg.

Echocardiography electronic data for Pulmonary Artery Pressure

Time Frame: 60 minutes during Echocardiography procedure

Cardiac function metric measurement including Pulmonary Artery Pressure to report in mmHg.

Cardiac Performance System electronic data for Pulmonary Artery Wedge Pressure

Time Frame: 60 minutes during Echocardiography procedure

Cardiac function metric measurement including Pulmonary Artery Wedge Pressure to report in mmHg

Cardiac Performance System electronic data for Ejection Fraction

Time Frame: 60 minutes during Echocardiography procedure

Cardiac function measurement including left ventricle ejection fraction to report in percentage

Cardiac Performance System electronic data for Cardiac Output

Time Frame: 60 minutes during Echocardiography procedure

Cardiac function metric measurement including Cardiac Output to report in L/m

Echocardiography electronic data for Ejection Fraction

Time Frame: 60 minutes during Echocardiography procedure

Cardiac function measurement including left ventricle ejection fraction to report in percentage

Echocardiography electronic data for Cardiac Output

Time Frame: 60 minutes during Echocardiography procedure

Cardiac function metric measurement including Cardiac Output to report in L/m

Echocardiography electronic data for Pulmonary Artery Wedge Pressure

Time Frame: 60 minutes during Echocardiography procedure

Cardiac function metric measurement including Pulmonary Artery Wedge Pressure to report in mmHg

Study Sites (1)

Loading locations...

Similar Trials